Clinical and Translational Radiation Oncology

Article	Citations
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility	31
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging	30
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors	25
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	22
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how	22
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	19
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	16
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	16
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy	16
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity	15
Association between radiotherapy protocol variations and outcome in the CONVERT trial	15
CD8-positive lymphocyte infiltration as a marker of anti-tumor immune response in rectal cancer: pre- and post-neoadjuvant radiotherapy comparison	15
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	15
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer	13
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study	13
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma	12
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial	12
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning model	12
Bulky non-small cell lung cancer treated with two-field robust proton lattice boost followed by conventional chemoradiation	11
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer	11
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	10
Deep learning [18F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy	10
Radiation response assessment of organoids derived from patients with pancreatic cancer	10
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	10
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer	10

Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas	9
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	9
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature	9
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC	8
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study	8
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning	8
Letter to the editor: Reply to Chen et al.	8
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study	8
Investigation of the physiological response of radiation-induced cystitis patients using hyperbaric oxygen	8
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients	8
Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials	8
Predicting late renal toxicity using a two-component repair model among pediatric patients receiving total body irradiation for stem cell transplant	8
Trends in use of magnetic resonance imaging and partial breast irradiation between 2011–2022 in the Netherlands: A population-based study	8
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures	8
Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity	8
Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery	8
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib	7
Artificial intelligence to predict outcomes of head and neck radiotherapy	7
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	7
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	7
Setting the stage: The opening act of preoperative SRS for brain metastases	7
Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma	7
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision	7
Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours	6
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study	6
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study	6
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	6
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	6
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	6
In regard to Kim et al	6
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis	6
Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status	6
Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma	6
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy	6
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation	6
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	6
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma	6
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice	6
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinoma	6
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020	6
Corrigendum to “Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy” [Clin. Translat. Radiat. Oncol. (2025) 100897]	6
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer	6
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy	6
Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: The prospective ReRad II trial	5
Access to brachytherapy treatment for cervical cancer management in Africa	5
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process	5
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma	5
The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey	5
Development and validation of cost-effective multi-sample hypoxia chambers for proton ultra-high dose rate organoid irradiations	5
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia	5

MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience	5
Artificial intelligence guided physician directive improves head and neck planning quality and practice Uniformity: A prospective study	5
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases	5
Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer	5
Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility	5
A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer	5
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgia	5
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study	5
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors	5
Salvage LATTICE radiotherapy for a growing tumour despite conventional radio chemotherapy treatment of lung cancer	5
The carbon footprint of external beam radiotherapy and its impact in health technology assessment	5
Deterioration of pancreatic exocrine function in carbon ion radiotherapy for pancreatic cancer	5
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	5
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis	5
The role of radiotherapy in the management of metastatic rectal cancer: A narrative review on the opportunities for non-operative management and organ preservation	5
Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors	5
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy	4
Prognostic factors, patterns of failure and re-irradiation in hypofractionated stereotactic radiotherapy-treated brain metastases from non-small cell lung cancer	4
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	4
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	4
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins	4
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses	4
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	4
Reirradiation with stereotactic radiosurgery for vestibular schwannomas – a systematic review and meta-analysis	4
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	4
Thyroid volume changes following adjuvant radiation therapy for breast cancer	4
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	4
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	4
Letter to the Editor	4
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial	4
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancers	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis	4
Combining CAR-T therapy with radiotherapy or not in refractory/relapsed diffuse large B-cell lymphoma: A comparative study	4
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study	4
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors	4
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario	4
#radonc: Growth of the global radiation oncology Twitter network	4
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma	4
Patient experience and shared decision-making in HPV-positive oropharyngeal cancer: A systematic review of qualitative and quantitative evidence	4
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature	4
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey	4
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance	4
Irradiation of localized prostate cancer in the elderly: A systematic literature review	4
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect	4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy	4
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	3
Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients – A systematic review and Meta-Analysis	3
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospecti	3
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results	3
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap	3
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation	3
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases	3
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population	3
Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population	3
Re-irradiation of recurrent lung tumours: Associations between dose and 2-year survival	3
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana	3
Detection of alteration in carotid artery volumetry using standard-of-care computed tomography surveillance scans following unilateral radiation therapy for early-stage tonsillar squamous cell carcino	3
Institutional experience of using active breathing control for paediatric and teenage patients receiving thoraco-abdominal radiotherapy	3
Optimizing predictive accuracy of the two-component repair model for pediatric TBI: Pediatric-specific parameters, toxicity endpoint harmonization, and dose-rate safeguards	3
The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook	3
Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)	3
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy	3
Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography	3
Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma	3
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
Adaptive radiotherapy for breast cancer	3
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery	3
PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer	3
Large language models for pretreatment education in pediatric radiation oncology: A comparative evaluation study	3
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	3
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study	3
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia	3

Same-Day Magnetic Resonance-Guided Single-Fraction Stereotactic Body Radiation Therapy for Painful Non-Spine Bone Metastases – A Single-Center Study (“BONE SHOT”)	3
Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy	3
Acute enteritis with pelvic SBRT: Influence of bowel delineation methods	3
Unmasking enteritis: reply to commentary titled “Clarifying Gastrointestinal toxicity attribution in WP-SBRT: A commentary on Dinesan et al. and proposal of a bladder-bowel displacement index”	3
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study	3
Online CBCT-based adaptive radiation with reduced PTV margins for prostate cancer: Does reference plan comparison tell the whole story?	3
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	3
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institutio	3
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer	3
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation	3
Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)	3
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer	3
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	3
SABR for oligometastatic renal cell carcinoma	3
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study	3
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial	3
Design and evaluation of a deep learning-based automatic segmentation of maxillary and mandibular substructures using a 3D U-Net	3
Prediction for cardiac and pulmonary toxicity in a multicentric cohort of advanced stage NSCLC patients using sub-regions of the heart	3
Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”	3
Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy	3
From pre-clinical studies to human treatment with proton-minibeam radiation therapy: adapted Idea, Development, Exploration, Assessment and Long-term evaluation (IDEAL) framework for innovation in rad	3
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy	3
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients	2
Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial	2
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer	2
Comparison of lifetime attributable risk of post-irradiation secondary cancer of boron neutron capture therapy, proton beam therapy, and X-ray therapy for pediatric and adolescent and young adult pati	2
Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma	2
Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial	2
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk	2
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy	2
Fractionated stereotactic radiotherapy of brainstem metastases – Clinical outcome and prognostic factors	2
Correlation between radiation dose to bone marrow subregions and acute hematologic toxicity inendometrial cancer treated with external beam radiotherapy	2
Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer	2
Impact of discrimination on training and career of radiation oncologists in France	2
Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional study	2
Radiation therapy for primary orbital and ocular adnexal lymphoma	2
Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists	2
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges	2
Efficacy and safety of the pudendal nerve block as a component of multimodal analgesia for cervical brachytherapy	2
Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study	2
Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases	2
Early complete tumor response as a survival predictor in hepatocellular carcinoma patients receiving stereotactic body radiation therapy	2
Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial	2
Young oncologists benefit more than experts from deep learning-based organs-at-risk contouring modeling in nasopharyngeal carcinoma radiotherapy: A multi-institution clinical study exploring working e	2
Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials	2
Increasing patient comfort in palliative radiotherapy with a newly developed mattress: a nonrandomized clinical trial	2
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterizat	2
Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net	2
4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases	2
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study	2
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys	2
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer	2
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)	2
10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event	2
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy	2
Application and progress of artificial intelligence in radiation therapy dose prediction	2
Feasibility and early toxicity of intraoperative radiotherapy for breast cancer using the papillon + system: First results	2
Corrigendum to “Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials”. [Clin. Translat. Radiat. Oncol	2
Impact of tumor position displacement during end-exhalation breath-hold condition on tumor dose in lung stereotactic body radiation therapy using volumetric modulated arc therapy	2
Clinical evaluation of a deep learning CBCT auto-segmentation software for prostate adaptive radiation therapy	2
The impact of rectal spacers in MR-guided adaptive radiotherapy	2
Radiotherapy boost to the primary tumour in locally advanced rectal cancer: Systematic review of practices and meta-analysis	2
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	2
Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours	2
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial	2
The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer	2
Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?	2
Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea	2
Is bilateral radiotherapy necessary for patients with unilateral squamous cell carcinoma of unknown primary of the head and neck region?	2
Mechanically assisted non-invasive ventilation for liver SABR: Improve CBCT, treat more accurately	2
Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic	2
Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma	2
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma	2
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group	2
A first evaluation of the efficacy of minibeam radiation therapy combined with an immune check point inhibitor in a model of glioma-bearing rats	2
Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer – Multi-centre study	2
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients	2
Evaluation of therapeutic radiographer target volume contouring for magnetic resonance image guided online adaptive bladder radiotherapy	2
Development and dissemination of structured hashtags for radiation oncology: Two-Year trends	2
SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic review	2
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control	2
New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis	2
Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer	2
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives	2
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma	2
How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists	2
Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model	2
18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer	2
Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer	2
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort	2
Metastases-directed local therapies (MDT) beyond genuine oligometastatic disease (OMD): Indications, endpoints and the role of imaging	2
Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study	2
Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer	2
Volumetric and spatial changes in brain metastases during stereotactic radiosurgery: a case for off-line adaptive planning	2
Deep inspirational breast hold (DIBH) for right breast irradiation: Improved sparing of liver and lung tissue	2